How close are we to customizing chemotherapy in early non-small cell lung cancer? by Georgios Ioannidis, Vassilis Georgoulias, John Souglakos

Get full text

Prognostic Significance of <i>TWIST1</i>, <i>CD24</i>, <i>CD44</i>, and <i>ALDH1</i> Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Can... by Areti Strati, Michail Nikolaou, Vassilis Georgoulias, Evi S. Lianidou

Get full text

Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR by Aliki Ntzifa, Athanasios Kotsakis, Vassilis Georgoulias, Evi Lianidou

Get full text

RNA-Based CTC Analysis Provides Prognostic Information in Metastatic Breast Cancer by Areti Strati, Michail Nikolaou, Vassilis Georgoulias, Evi S. Lianidou

Get full text

The Place of Targeted Agents in the Treatment of Elderly Patients with Metastatic Colorectal Cancer by Alexios Matikas, Natalia Asimakopoulou, Vassilis Georgoulias, John Souglakos

Get full text

Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs) by Galatea Kallergi, Eleni Politaki, Saad Alkahtani, Christos Stournaras, Vassilis Georgoulias

Get full text

DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment by Aliki Ntzifa, Dora Londra, Theodoros Rampias, Athanasios Kotsakis, Vassilis Georgoulias, Evi Lianidou

Get full text

Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients by Aliki Ntzifa, Areti Strati, Galatea Kallergi, Athanasios Kotsakis, Vassilis Georgoulias, Evi Lianidou

Get full text

PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC) by Evangelia Pantazaka, Aliki Ntzifa, Argyro Roumeliotou, Evi Lianidou, Vassilis Georgoulias, Athanasios Kotsakis, Galatea Kallergi

Get full text

<i>ESR1</i> NAPA Assay: Development and Analytical Validation of a Highly Sensitive and Specific Blood-Based Assay for the Detection of <i>ESR1</i> Mutations in Liquid Biopsies by Dimitra Stergiopoulou, Athina Markou, Eleni Tzanikou, Ioannis Ladas, G. Mike Makrigiorgos, Vassilis Georgoulias, Evi Lianidou

Get full text

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study by Eleni Tzanikou, Athina Markou, Eleni Politaki, Anastasios Koutsopoulos, Amanda Psyrri, Dimitris Mavroudis, Vassilis Georgoulias, Evi Lianidou

Get full text

Small Extracellular Vesicles in Pre-Therapy Plasma Predict Clinical Outcome in Non-Small-Cell Lung Cancer Patients by Eleni-Kyriaki Vetsika, Priyanka Sharma, Ioannis Samaras, Alexandra Markou, Vassilis Georgoulias, Theresa L. Whiteside, Athanasios Kotsakis

Get full text

Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact by Vasileios Vardas, Anastasios Tolios, Athina Christopoulou, Vassilis Georgoulias, Anastasia Xagara, Filippos Koinis, Athanasios Kotsakis, Galatea Kallergi

Get full text

PARP-1 Expression and <i>BRCA1</i> Mutations in Breast Cancer Patients’ CTCs by Thodoris Sklias, Vasileios Vardas, Evangelia Pantazaka, Athina Christopoulou, Vassilis Georgoulias, Athanasios Kotsakis, Yiannis Vasilopoulos, Galatea Kallergi

Get full text

Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer by Dimitra Stergiopoulou, Athina Markou, Areti Strati, Martha Zavridou, Eleni Tzanikou, Sophia Mastoraki, Galatea Kallergi, Vassilis Georgoulias, Evi Lianidou

Get full text

CD8 PD-1 T-cells and PD-L1 circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance? by Athanasios Kotsakis, Galatea Kallergi, Despoina Aggouraki, Zaharoula Lyristi, Filippos Koinis, Eleni Lagoudaki, Anastasios Koutsopoulos, Vassilis Georgoulias, Eleni-Kyriaki Vetsika

Get full text

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell... by Maria A. Papadaki, Ippokratis Messaritakis, Oraianthi Fiste, John Souglakos, Eleni Politaki, Athanasios Kotsakis, Vassilis Georgoulias, Dimitrios Mavroudis, Sofia Agelaki

Get full text

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer. by Sofia Agelaki, Antonia Kalykaki, Harris Markomanolaki, Maria A Papadaki, Galatea Kallergi, Dora Hatzidaki, Kostas Kalbakis, Dimitrios Mavroudis, Vassilis Georgoulias

Get full text

KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer. by Aristea Kalikaki, Helen Politaki, John Souglakos, Stella Apostolaki, Elisavet Papadimitraki, Nefeli Georgoulia, Maria Tzardi, Dimitris Mavroudis, Vassilis Georgoulias, Alexandra Voutsina

Get full text

Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology by Vasileios Vardas, Julia A. Ju, Athina Christopoulou, Anastasia Xagara, Vassilis Georgoulias, Athanasios Kotsakis, Catherine Alix-Panabières, Stuart S. Martin, Galatea Kallergi

Get full text